regenerative medicine
regenerative medicine
Revolutionary CDMO Set to Transform Stem Cell Therapies!
🌟 Mytos launches automated CDMO for stem-cell therapies! 🔬 Tackling manufacturing challenges, aiming for 1,500 doses annually by 2026! 🚀🌍
PromoCell’s Game-Changer: GMP Cell Culture Media!
🌟 PromoCell adopts GMP standards for custom cell culture media! 🔬 Essential for cell-based therapies and regenerative medicine. 🧪 Join us at ESGCT! 📈
Unlocking Stem Cell Binding: Speed Matters!
**Excerpt:** 🌟 Discover how ligand-receptor speed and interaction strength enhance stem cell binding, revolutionizing biomaterials for tissue engineering! 🔍💡
Revolutionary Bioprocessing: The Future of Medicine!
🌱 Bioprocessing is revolutionizing medicine! 🚀 Recent advancements enhance drug development, making therapies safer, faster, and more affordable. 🤖💉
Revolutionary Artificial Platelet Breakthrough for Medicine!
🌟 Breakthrough in biotechnology! PL BioScience produces artificial human platelet lysate for cell culture, supporting regenerative medicine and biopharma. 🤝💡🔬
Revolutionary Partnership: Automating Stem Cells for Parkinson’s!
🚀 Exciting partnership! Mytos and Aspen team up to automate stem cell production for Parkinson’s therapy, enhancing efficiency and reducing costs! 🧬🏭💡
Cellino’s $25M Boost for Personalized Medicine Revolution!
🌟 Cellino Biotech secures $25M from ARPA-H to boost NEBULA project, revolutionizing personalized regenerative medicine and promoting health equity! 🔬🧬❤️🚀
EMA Approves 10 New Life-Changing Medicines!
📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉
Breakthrough: Affordable Customised Albumin Revolutionizes Therapeutics
📅 January 22, 2024. Demand for animal-free recombinant albumin has led to high prices, limiting access to affordable vaccines and monoclonal antibodies. New technologies are increasing production and expanding its use beyond therapeutics to skincare. Albumin is widely used in diagnostics, medical devices, and regenerative medicine. Patent protections and limited suppliers have created shortages. Lower quality albumin is affordable but presents manufacturing and regulatory issues. Customised strains of baker's yeast are now enabling the production of high-quality, affordable albumin. This could accelerate research and unleash the full potential of albumin. ✨🧪💉🌿🔬💊📈